Literature DB >> 34011371

Participatory research for the development of information, education and communication tools to promote intermittent preventive treatment of malaria in pregnancy in the Democratic Republic of the Congo, Nigeria and Mozambique.

Sylvain Landry Birane Faye1, Maud Majeres Lugand2.   

Abstract

BACKGROUND: To improve the coverage of intermittent preventive treatment of malaria in pregnancy (IPTp) in Africa, Medicines for Malaria Venture (MMV) developed, tested and validated a new packaging of sulfadoxine-pyrimethamine (SP), as well as specific communications tools designed to improve knowledge of IPTp and the motivation of women to adhere to it, particularly if it is distributed by community health workers (CHW).
METHODS: This article describes and analyses the results of an empirical research carried out in the Democratic Republic of the Congo (DRC), Nigeria and Mozambique, to evaluate the perception and social acceptability of SP for healthcare providers, CHW and pregnant women, and to assess the ability of the new SP packaging and the communications tools to change their perception of SP and improve their attitudes towards IPTp.
RESULTS: The results indicate that SP's new individual packaging was perceived by pregnant women and healthcare providers as a "hygienic" and "safe", with a specific identity. The graphics used in IPTp communications tools were modified according to the respondents' feedback to make them more culturally and socially sensitive, and then validated. However, although the new blister packaging and IPTp communications tools generated greater confidence and motivation, SP side effects as well as preconceived ideas, particularly regarding its efficacy, remain a challenge that must be addressed to improve IPTp acceptance and compliance by healthcare providers and pregnant women.
CONCLUSION: This participatory approach to social research based on ongoing feedback to the graphic designer provided more empirical evidence to improve and adapt the textual and visual content of communication tools (SP blister packaging, leaflet, user guide) to local contexts and user preferences. Tested and validated in different socio-cultural and socio-political contexts, these tools provide a good basis for the promotion of IPTp in Africa.

Entities:  

Keywords:  Communication tools; IPTp; Malaria; Pregnancy; Sub-Saharan Africa; Sulfadoxine–pyrimethamine

Year:  2021        PMID: 34011371     DOI: 10.1186/s12936-021-03765-4

Source DB:  PubMed          Journal:  Malar J        ISSN: 1475-2875            Impact factor:   2.979


  24 in total

Review 1.  Combination therapy for malaria in Africa: hype or hope?

Authors:  P B Bloland; M Ettling; S Meek
Journal:  Bull World Health Organ       Date:  2003-11-17       Impact factor: 9.408

2.  Intermittent sulphadoxine-pyrimethamine to prevent severe anaemia secondary to malaria in pregnancy: a randomised placebo-controlled trial.

Authors:  C E Shulman; E K Dorman; F Cutts; K Kawuondo; J N Bulmer; N Peshu; K Marsh
Journal:  Lancet       Date:  1999-02-20       Impact factor: 79.321

3.  Effect of Plasmodium falciparum sulfadoxine-pyrimethamine resistance on the effectiveness of intermittent preventive therapy for malaria in pregnancy in Africa: a systematic review and meta-analysis.

Authors:  Anna Maria van Eijk; David A Larsen; Kassoum Kayentao; Gibby Koshy; Douglas E C Slaughter; Cally Roper; Lucy C Okell; Meghna Desai; Julie Gutman; Carole Khairallah; Stephen J Rogerson; Carol Hopkins Sibley; Steven R Meshnick; Steve M Taylor; Feiko O Ter Kuile
Journal:  Lancet Infect Dis       Date:  2019-03-25       Impact factor: 25.071

4.  Intermittent sulfadoxine-pyrimethamine in pregnancy: effectiveness against malaria morbidity in Blantyre, Malawi, in 1997-99.

Authors:  S J Rogerson; E Chaluluka; M Kanjala; P Mkundika; C Mhango; M E Molyneux
Journal:  Trans R Soc Trop Med Hyg       Date:  2000 Sep-Oct       Impact factor: 2.184

Review 5.  Effect of sulfadoxine-pyrimethamine resistance on the efficacy of intermittent preventive therapy for malaria control during pregnancy: a systematic review.

Authors:  Feiko O ter Kuile; Annemieke M van Eijk; Scott J Filler
Journal:  JAMA       Date:  2007-06-20       Impact factor: 56.272

6.  Impact of chloroquine resistance on malaria mortality.

Authors:  J F Trape; G Pison; M P Preziosi; C Enel; A Desgrées du Loû; V Delaunay; B Samb; E Lagarde; J F Molez; F Simondon
Journal:  C R Acad Sci III       Date:  1998-08

7.  The efficacy of antimalarial regimens containing sulfadoxine-pyrimethamine and/or chloroquine in preventing peripheral and placental Plasmodium falciparum infection among pregnant women in Malawi.

Authors:  L J Schultz; R W Steketee; A Macheso; P Kazembe; L Chitsulo; J J Wirima
Journal:  Am J Trop Med Hyg       Date:  1994-11       Impact factor: 2.345

8.  Knowledge and utilization of intermittent preventive treatment for malaria among pregnant women attending antenatal clinics in primary health care centers in rural southwest, Nigeria: a cross-sectional study.

Authors:  Stella O Akinleye; Catherine O Falade; Ikeoluwapo O Ajayi
Journal:  BMC Pregnancy Childbirth       Date:  2009-07-09       Impact factor: 3.007

Review 9.  Why are IPTp coverage targets so elusive in sub-Saharan Africa? A systematic review of health system barriers.

Authors:  Sylla Thiam; Victoria Kimotho; Patrick Gatonga
Journal:  Malar J       Date:  2013-10-03       Impact factor: 2.979

10.  Assessing supply-side barriers to uptake of intermittent preventive treatment for malaria in pregnancy: a qualitative study and document and record review in two regions of Uganda.

Authors:  Christian Rassi; Kirstie Graham; Patrobas Mufubenga; Rebecca King; Joslyn Meier; Sam Siduda Gudoi
Journal:  Malar J       Date:  2016-07-04       Impact factor: 2.979

View more
  1 in total

Review 1.  It Is Time to Strengthen the Malaria Control Policy of the Democratic Republic of Congo and Include Schools and School-Age Children in Malaria Control Measures.

Authors:  Sabin S Nundu; Shirley V Simpson; Hiroaki Arima; Jean-Jacques Muyembe; Toshihiro Mita; Steve Ahuka; Taro Yamamoto
Journal:  Pathogens       Date:  2022-06-26
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.